{
    "Trade/Device Name(s)": [
        "chromID\u2122 MRSA"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K151688",
    "Predicate Device Reference 510(k) Number(s)": [
        "K100589"
    ],
    "Regulatory Class": "II",
    "Product Code(s)": [
        "JSO"
    ],
    "Summary Letter Date": "February 4, 2016",
    "Summary Letter Received Date": "February 8, 2016",
    "Submission Date": "February 4, 2016",
    "Regulation Number(s)": [
        "21 CFR 866.1700"
    ],
    "Regulation Name(s)": [
        "Culture medium for antimicrobial susceptibility tests"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Methicillin-resistant Staphylococcus aureus (MRSA)"
    ],
    "Specimen Type(s)": [
        "Anterior nares swab",
        "Skin and skin structure specimens"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Selective chromogenic culture medium"
    ],
    "Methodologies": [
        "Chromogenic culture",
        "Manual inoculation and reading"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Culture medium"
    ],
    "Document Summary": "FDA 510(k) summary for chromID\u2122 MRSA selective and differential chromogenic medium for detection of MRSA.",
    "Indications for Use Summary": "For the qualitative detection of MRSA colonization in anterior nares and skin/skin structure infection specimens to aid in prevention and control of MRSA in healthcare settings; not intended to diagnose, guide, or monitor therapy for MRSA infections or provide methicillin susceptibility results.",
    "fda_folder": "Microbiology"
}